Objective. To compare antiplatelet efficacy of original clopidogrel and its generic analogue after implantation of Russian drug-eluting stents. Material and methods. Considering ADP-induced platelet aggregation, we compared aggregation in 3 and 30 days after intake of original and generic clopidogrel. Results. After 3 days, ADP-induced platelet aggregation was 36.5% and 39.1%, after a month — 38.9% and 43.7%, respectively. There were no major cardiac events (cardiac death, non-fatal acute myocardial infarction, stroke, stent thrombosis, stent restenosis, repeated target vessel revascularization, recurrence or progression of angina pectoris) throughout 12-52 months after stenting. Conclusion. We found no significant between-group difference in ADP-induced platelet aggregation and incidence of major cardiac events.
1 January 2018 in Russian Electronic Journal of Radiology